Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
April 24, 2019 Off

Blue Earth Diagnostics Announces Presentations on Axumin® (Fluciclovine F 18), 18F-Fluciclovine and 18F-rhPSMA at Upcoming American Urological Association’s 2019 Annual Meeting

By BusinessWire

BURLINGTON, Mass. & OXFORD, England–(BUSINESS WIRE)–Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced upcoming presentations at the American…

April 24, 2019 Off

X4 Pharmaceuticals Appoints E. Lynne Kelley, M.D. as Chief Medical Officer

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the…

April 24, 2019 Off

Magenta Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of MGTA-145, a First-Line Stem Cell Mobilization Product Candidate

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem…

April 24, 2019 Off

Global Healthcare CMO Market Forecasts (2019-2023 Edition) with Profiles on Catalent Pharma Solution, Recipharm, Aurobindo Pharma and Boehringher Ingelheim – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Healthcare CMO Market (2019-2023 Edition)” report has been added to ResearchAndMarkets.com’s offering. Global Healthcare CMO Market (2019-2023…

April 24, 2019 Off

Syros to Report First Quarter 2019 Financial Results on Wednesday, May 1, 2019

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company pioneering the discovery and development of medicines to control the expression of…

April 24, 2019 Off

Bicycle Therapeutics to Present Immune Oncology CD137 Data on Multivalent and Tumor-targeted Bispecific Bicycles at Peptides Congress

By BusinessWire

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic…

April 24, 2019 Off

USD$90 Million Initiative between A*Star, Aptorum Group and Aeneas Capital to Drive Healthcare Innovations

By BusinessWire

HONG KONG & SINGAPORE–(BUSINESS WIRE)–Aptorum Group Limited (Nasdaq: APM), Aeneas Capital Limited, and A*ccelerate Technologies Pte Ltd, the enterprise office…

April 24, 2019 Off

Arrowhead Begins Triple Combination Cohort in Chronic HBV Patients and Earns $25 Million Milestone Payment from Janssen

By BusinessWire

PASADENA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24arwr&src=ctag" target="_blank"gt;$arwrlt;/agt;–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has begun dosing in a new triple…

April 24, 2019 Off

Cavion to Present Results of Phase 2 Essential Tremor Clinical Trial in Platform Presentation at the American Academy of Neurology

By BusinessWire

Presentation to provide overview of Phase 2 T-CALM study design, results and clinical path forward CHARLOTTESVILLE, Va. & CAMBRIDGE, Mass.–(BUSINESS…

April 24, 2019 Off

Spark Therapeutics CEO and Former Merck President to Keynote Veeva Commercial & Medical Summit

By BusinessWire

Industry leaders to discuss the impact of advanced innovation on commercial models and driving improved patient outcomes PLEASANTON, Calif.–(BUSINESS WIRE)–lt;a…

Posts pagination

Previous 1 … 3,255 3,256 3,257 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine